Results 251 to 260 of about 3,363,784 (294)
Some of the next articles are maybe not open access.
Current Opinion in Oncology, 2006
This article will review the diagnosis and management of bladder cancer at each stage, from superficial to metastatic disease with an emphasis on recent developments over the last year.Bacille Calmette-Guerin is the most effective therapy for carcinoma in situ.
Eric S, Gwynn, Peter E, Clark
openaire +2 more sources
This article will review the diagnosis and management of bladder cancer at each stage, from superficial to metastatic disease with an emphasis on recent developments over the last year.Bacille Calmette-Guerin is the most effective therapy for carcinoma in situ.
Eric S, Gwynn, Peter E, Clark
openaire +2 more sources
Current Opinion in Oncology, 2010
To review the diagnosis and management of all stages of bladder cancer with an emphasis on studies and developments within the last year.Cystoscopy remains the gold standard for diagnosis of bladder tumors, though fluorescent light and urinary biomarkers can both improve the sensitivity of cancer detection.
Todd M, Morgan, Peter E, Clark
openaire +2 more sources
To review the diagnosis and management of all stages of bladder cancer with an emphasis on studies and developments within the last year.Cystoscopy remains the gold standard for diagnosis of bladder tumors, though fluorescent light and urinary biomarkers can both improve the sensitivity of cancer detection.
Todd M, Morgan, Peter E, Clark
openaire +2 more sources
Current Opinion in Oncology, 2008
To review the diagnosis and management of bladder cancer with an emphasis on studies and developments over the past year.Cystoscopy remains the mainstay in the detection and surveillance of bladder cancer, though fluorescent light may enhance detection. Efforts continue in the development of urinary bladder cancer markers. Superficial bladder cancer is
Daniel A, Barocas, Peter E, Clark
openaire +2 more sources
To review the diagnosis and management of bladder cancer with an emphasis on studies and developments over the past year.Cystoscopy remains the mainstay in the detection and surveillance of bladder cancer, though fluorescent light may enhance detection. Efforts continue in the development of urinary bladder cancer markers. Superficial bladder cancer is
Daniel A, Barocas, Peter E, Clark
openaire +2 more sources
The American Journal of Nursing, 1958
AFEW isolated facts and statistics were all that I knew about cancer of the bladder until I met a patient named Mr. John Jones. I knew that cancer of the bladder accounted for 3 percent of the total cancer death rate, and that these deaths resulted from ureteral obstruction, infection, uremia, and metastases.
openaire +2 more sources
AFEW isolated facts and statistics were all that I knew about cancer of the bladder until I met a patient named Mr. John Jones. I knew that cancer of the bladder accounted for 3 percent of the total cancer death rate, and that these deaths resulted from ureteral obstruction, infection, uremia, and metastases.
openaire +2 more sources
Current Opinion in Oncology, 2003
This article reviews recent advances in the diagnosis and management of bladder cancer.Bladder cancer is a significant cause of morbidity and mortality. Recent research has attempted to improve the care of patients with this disease. Evidence suggests that bacillus Calmette-Guerin is the most effective intravesical therapy for the treatment of ...
Lester S, Borden +2 more
openaire +4 more sources
This article reviews recent advances in the diagnosis and management of bladder cancer.Bladder cancer is a significant cause of morbidity and mortality. Recent research has attempted to improve the care of patients with this disease. Evidence suggests that bacillus Calmette-Guerin is the most effective intravesical therapy for the treatment of ...
Lester S, Borden +2 more
openaire +4 more sources
Journal of the Royal Society for the Promotion of Health, 2004
Bladder cancer is the fifth most common malignancy in Europe and the fourth most common malignancy in the United States. 1 It affects one in 4000 people and accounts for 5% of all diagnosed cancers. The peak incidence is in the fifth and seventh decade.
N, Sengupta +2 more
openaire +2 more sources
Bladder cancer is the fifth most common malignancy in Europe and the fourth most common malignancy in the United States. 1 It affects one in 4000 people and accounts for 5% of all diagnosed cancers. The peak incidence is in the fifth and seventh decade.
N, Sengupta +2 more
openaire +2 more sources
Current Opinion in Oncology, 2000
There is a need for the development of reliable tumor markers in bladder cancer. A number of studies this past year focused on the evaluation of urinary markers that hold promise as noninvasive adjuncts to traditional diagnostic or surveillance techniques, principally urinary cytology and cystoscopy.
Ozen, H, Hall, MC
openaire +3 more sources
There is a need for the development of reliable tumor markers in bladder cancer. A number of studies this past year focused on the evaluation of urinary markers that hold promise as noninvasive adjuncts to traditional diagnostic or surveillance techniques, principally urinary cytology and cystoscopy.
Ozen, H, Hall, MC
openaire +3 more sources
Current Opinion in Oncology, 1992
In the search for sensitive and specific tumor markers for bladder carcinoma, expression of various oncogenes and gene products (such as c-erb B-2, p53) and epidermal growth factor receptor merits particular attention. Although the results are not yet conclusive, important predictive markers are about to emerge from ongoing studies in this field ...
openaire +6 more sources
In the search for sensitive and specific tumor markers for bladder carcinoma, expression of various oncogenes and gene products (such as c-erb B-2, p53) and epidermal growth factor receptor merits particular attention. Although the results are not yet conclusive, important predictive markers are about to emerge from ongoing studies in this field ...
openaire +6 more sources
JAMA, 2020
Bladder cancer is a common malignancy in women and is the fourth most common malignancy in men. Bladder cancer ranges from unaggressive and usually noninvasive tumors that recur and commit patients to long-term invasive surveillance, to aggressive and invasive tumors with high disease-specific mortality.Advanced age, male sex, and cigarette smoking ...
Andrew T, Lenis +3 more
openaire +2 more sources
Bladder cancer is a common malignancy in women and is the fourth most common malignancy in men. Bladder cancer ranges from unaggressive and usually noninvasive tumors that recur and commit patients to long-term invasive surveillance, to aggressive and invasive tumors with high disease-specific mortality.Advanced age, male sex, and cigarette smoking ...
Andrew T, Lenis +3 more
openaire +2 more sources
Current Opinion in Oncology, 1990
Bladder cancer is largely a preventable disease; epidemiologic studies indicate that the majority of cases occur as a result of cigarette smoking or occupational exposures. The impact of screening high-risk populations is uncertain, but prompt and early diagnosis is essential for optimal therapeutic results.
openaire +4 more sources
Bladder cancer is largely a preventable disease; epidemiologic studies indicate that the majority of cases occur as a result of cigarette smoking or occupational exposures. The impact of screening high-risk populations is uncertain, but prompt and early diagnosis is essential for optimal therapeutic results.
openaire +4 more sources